Sign in
Stories
Philips Delivers Strong Results, Resolves Recall
Share
Philips Faces Stock Slump Over Sleep Apn...
FDA Warns on CPAP Safety Issues
Overview
API
Philips, a health technology company, achieved strong full-year results and is working with the FDA to resolve a respiratory device recall. The CEO emphasized the company's focus on patient safety and quality, and announced a plan for 2023-2025. Philips has reduced its workforce by 8,000 roles and achieved productivity savings of EUR 956 million in 2023.
Ask a question
How might Philips' focus on patient safety and quality impact the healthcare industry as a whole?
What are the potential long-term effects of Philips' efforts to resolve the respiratory device recall on its reputation and financial performance?
What strategies could other companies adopt to achieve similar productivity savings and workforce reductions?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage